
Sign up to save your podcasts
Or
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
4.3
1818 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
131 Listeners
325 Listeners
161 Listeners
496 Listeners
707 Listeners
38 Listeners
281 Listeners
3,336 Listeners
9 Listeners
18 Listeners
14 Listeners
11 Listeners
5 Listeners
7 Listeners
9 Listeners
21 Listeners
90 Listeners
138 Listeners
1,095 Listeners
5 Listeners
29 Listeners
14 Listeners
185 Listeners
519 Listeners
5 Listeners
349 Listeners
427 Listeners
106 Listeners
20 Listeners
366 Listeners
2 Listeners
163 Listeners